Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells

Neuroscience Letters

Volumn 330, Issue 2, 2002, Pages 147-150

  Tanaka, Ken Ichi ^a   Fujita, Naoko ^a   Higashi, Youichirou ^a   Ogawa, Norio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Antioxidant; FK506; Glutathione; GPI1046; Hydrogen peroxide; Neuroimmunophilin

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; FK 506 BINDING PROTEIN; GLUTATHIONE; IMMUNOPHILIN; ISOPROTEIN; LIGAND; MESSENGER RNA; TACROLIMUS;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DRUG EFFECT; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NEUROBLASTOMA CELL; NEUROPROTECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING;

ACTINS; ANTIOXIDANTS; CELL SURVIVAL; COLORIMETRY; DIMETHYL SULFOXIDE; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; IMMUNOSUPPRESSIVE AGENTS; NEUROPROTECTIVE AGENTS; PEPTIDYLPROLYL ISOMERASE; PYRROLIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TACROLIMUS; TACROLIMUS BINDING PROTEIN 1A; TACROLIMUS BINDING PROTEINS; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0037144133     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00755-3     Document Type: Article

References (20)

1. Costantini L.C., Chaturvedi P., Armistead D.M., McCaffrey P.G., Deacon T.W., Isacson O. A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease. Neurobiol. Dis. 5:1998;97-108.
2. Costantini L.C., Cole D., Chaturvedi P., Isacson O. Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease. Eur. J. Neurosci. 13:2001;1085-1092.
3. Gold B.G., Densmore V., Shou W., Matzuk M.M., Gordon H.S. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 289:1999;1202-1210.
4. Gold B.G., Zeleny-Pooley M., Wang M.-S., Chaturvedi P., Aemistead D.M. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147:1997;269-278.
5. Guo X., Dawson V.L., Dawson T.M. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur. J. Neurosci. 13:2001;1683-1693.
6. Happer S., Bilsland J., Young L., Bristow L., Boyce S., Mason G., Rigby M., Hewson L., Smith D., O'Donell R., O'Connor D., Hill R.G., Evans D., Swain C., Williams B., Hefti F. Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo. Neuroscience. 88:1999;257-267.
7. Herdegen T., Fischer G., Gold B.G. Immunophilin ligands as a novel treatment for neurological disorders. Trends Pharmacol. Sci. 21:2000;3-5.
8. Kay J.E. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. Biochem. J. 314:1996;361-385.
9. Liu J., Farmer J.D.J., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
10. Marks A.R. Cellular functions of immunophilins. Physiol. Rev. 76:1996;631-649.
11. Owens-Grillo J.K., Czar M.J., Hutchison K.A., Hoffmann K., Perdew G.H., Pratt W.B. A model of protein targeting mediated by immunophilins and other proteins that bind to hsp90 via tetratricopeptide repeat domains. J. Biol. Chem. 271:1996;13468-13475.
12. Ross D.T., Guo H., Howorth P., Chen Y., Hamilton G.S., Steiner J.P. The small molecule FKBP ligand GPI 1046 induces partial striatal re-innervation after intranigral 6-hydroxydopamine lesion in rats. Neurosci. Lett. 297:2001;113-116.
13. Snyder S.H., Sabatini D.M., Lai M.M., Steiner J.P., Hamilton G.S., Suzdak P.D. Neural actions of immunophilin ligands. Trends Pharmacol. Sci. 19:1998;21-26.
14. Steiner J.P., Dawson T.M., Fotuhi M., Glatt C.E., Snowman A.M.M., Cohen N., Snyder S.H. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature. 358:1992;584-587.
15. Steiner J.P., Hamilton G.S., Rose D.T., Valentine H.L., Guo H., Connolly M.A., Liang S., Ramsey C., Li J.H., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A.C., Suzdak P.D. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA. 94:1997;2019-2024.
16. 2-induced apoptotic cell death by increasing glutathione levels in Neuro 2A neuroblastoma cells. Acta Med. Okayama. 54:2000;275-280.
17. Tanaka K., Fujita N., Higashi Y., Ogawa N. Effects of immunophilin ligands on hydrogen peroxide-induced apoptosis in C6 glioma cells. Synapse. 43:2002;219-222.
18. 2-induced cell damage by increasing glutathione levels in NG108-15 cells. Brain Res. 889:2001;236-239.
19. Tanaka K., Yoshioka M., Miyazaki I., Fujita N., Ogawa N. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum. Neurosci. Lett. 321:2002;45-48.
20. Winter C., Schenkel J., Bürger E., Eickmeier C., Zimmermann M., Herdegen T. The immunophilin ligand FK506, but not GPI-1046, protects against neuronal death and inhibits c-Jun expression in the substantia nigra pars compacta following transection of the rat medial forebrain bundle. Neuroscience. 95:2000;753-762.